US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents

Patent 8946163 was granted and assigned to MIMEDX GROUP, INC. on February, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

MIMEDX GROUP, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8946163

Patent Inventor Names

Thomas J. Koob0

Date of Patent

February 3, 2015

Patent Application Number

13815834

Date Filed

March 15, 2013

Patent Citations Received

‌

US Patent 12076348 Micronized placental compositions comprising a chelator

Patent Primary Examiner

‌

Karlheinz R. Skowronek

Patent abstract

The disclosure describes collagen constructs comprising anticancer agents, preferably, platinum, and related methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API